Your browser is no longer supported. Please, upgrade your browser.
PFE Pfizer Inc. daily Stock Chart
Pfizer Inc.
IndexDJIA S&P500 P/E28.86 EPS (ttm)1.22 Insider Own0.10% Shs Outstand6.06B Perf Week1.79%
Market Cap213.54B Forward P/E13.42 EPS next Y2.62 Insider Trans-13.61% Shs Float6.06B Perf Month1.32%
Income7.59B PEG3.69 EPS next Q0.62 Inst Own76.50% Short Float0.92% Perf Quarter18.26%
Sales50.99B P/S4.19 EPS this Y-21.50% Inst Trans1.48% Short Ratio1.50 Perf Half Y9.56%
Book/sh10.25 P/B3.44 EPS next Y7.54% ROA- Target Price38.67 Perf Year8.21%
Cash/sh3.21 P/C10.98 EPS next 5Y7.82% ROE- 52W Range27.71 - 35.50 Perf YTD11.16%
Dividend1.20 P/FCF- EPS past 5Y1.60% ROI8.00% 52W High-0.08% Beta0.85
Dividend %3.41% Quick Ratio1.20 Sales past 5Y-5.60% Gross Margin79.20% 52W Low27.99% ATR0.49
Employees97900 Current Ratio1.40 Sales Q/Q19.70% Oper. Margin- RSI (14)63.07 Volatility1.54% 1.39%
OptionableYes Debt/Eq0.62 EPS Q/Q28.90% Profit Margin- Rel Volume0.48 Prev Close35.21
ShortableYes LT Debt/Eq0.44 EarningsAug 02 BMO Payout- Avg Volume37.23M Price35.47
Recom2.20 SMA202.14% SMA504.44% SMA20011.20% Volume4,460,521 Change0.74%
Jun-20-16Reiterated Jefferies Buy $42 → $40
May-12-16Initiated Berenberg Hold $38
May-04-16Reiterated UBS Buy $36 → $38
Apr-18-16Resumed Goldman Neutral $35
Apr-07-16Resumed Morgan Stanley Equal-Weight $35
Apr-07-16Resumed JP Morgan Overweight $38
Nov-25-15Upgrade Sun Trust Rbsn Humphrey Reduce → Neutral
Nov-03-15Reiterated Argus Buy $41 → $46
Oct-28-15Reiterated Deutsche Bank Buy $41 → $43
Oct-02-15Upgrade Morgan Stanley Equal-Weight → Overweight $35 → $38
Jul-29-15Reiterated Argus Buy $39 → $41
Jun-17-15Initiated Piper Jaffray Overweight
Apr-30-15Reiterated Argus Buy $36 → $39
Apr-29-15Downgrade Citigroup Buy → Neutral
Jan-28-15Reiterated Argus Buy $35 → $36
Dec-18-14Reiterated Deutsche Bank Buy $34 → $35
Jul-02-13Downgrade Standpoint Research Hold → Sell $24
Apr-15-13Reiterated Barclays Equal Weight $25 → $32
Jan-30-13Reiterated UBS Buy $29 → $31
Jan-30-13Reiterated Argus Buy $28 → $32
Jul-01-16 11:06AM  Why AbbVie Expects PTK7 to Enhance Its Oncology Capabilities
10:43AM  Alternate Dosage Forms Are Expected to Drive Akorns Growth in 2016
09:54AM  Biogen: Not Worth A Buy Unless It Buys
09:09AM  How Are Pfizers Business Segments Performing?
08:10AM  Sometimes you have to turn away revenue to protect your brand at
Jun-30-16 06:40PM  Traders spot relative value in biotech at CNBC
06:31PM  Tesaro Stock Up on Successful Phase III Ovarian Cancer Trial
06:21PM  141 Reasons to Love Biotech Stocks at Motley Fool
05:00PM  The 4 Best biotech trades right now
04:24PM  How Akorns Valuation Multiples Compare to Peers in 2016
02:21PM  How Pfizer Continues Its Organic and Inorganic Growth
02:20PM  Is Pfizers Valuation Low Compared to Peers?
01:49PM  New partnership looks to improve lives of children living with HIV at
12:45PM  Pfizer's Rally Is Losing Momentum
11:01AM  [$$] Who Will Acquire Medivation? at
Jun-29-16 06:40PM  This Biotechs Stock Just Doubled and Its Bad News for Sanofi at Fortune
01:10PM  How Pfizer, Merck May Feel Long-Term Pinch From Brexit
12:28PM  How J&J Defied Brexit and Became the Year's Top Health Care Stock
12:22PM  Pfizer: Why a Big Acquisition is Needed After Possible Split
11:09AM  Pfizer's PCSK9 Inhibitor Tops Two Additional Phase III Studies
10:10AM  Company News for June 29, 2016
09:00AM  Research Report Initiated on Select Major Drug Manufacturers Equities
08:00AM  AstraZenecas cholesterol-drug gambit is the latest tactic from a company skilled at them
08:00AM  Why Pfizer Just Bet $350 Million On China (PFE) at Investopedia
01:30AM  Allergan Seeks Smaller M&A for Growth After Pfizer Breakup at Bloomberg
Jun-28-16 06:30PM  Pharmaceutical Companies May Abandon UK Acquisition Plans
04:35PM  Pfizer to Build $350M Biotech Center in China (PFE) at Investopedia
04:24PM  Think Healthcare M&A Is Dead? Think Again. at Motley Fool
11:25AM  Pfizer Investing $350M in China Biotech Center at TheStreet
10:38AM  Pfizer Investing $350M in China, Setting up Biotech Center
10:18AM  Heres Why Traders Are Watching These Stocks Today at Insider Monkey
10:03AM  5 Medical Stocks to Buy with Great Dividend Yields
09:42AM  Pfizer (PFE) Stock Gains on China Investment
09:26AM  Pfizer Inc. breached its 50 day moving average in a Bearish Manner : PFE-US : June 28, 2016
09:07AM  Mylans Profits: Can You Expect Changes?
08:30AM  Two Additional Phase 3 Lipid-Lowering Studies of Bococizumab Deliver Positive Topline Results Business Wire
12:50AM  Pfizer to invest $350 million in China biotech hub, first in Asia Reuters
12:47AM  Pfizer to invest $350 mln in China biotech hub, first in Asia Reuters
Jun-27-16 11:30PM  Pfizer Advances Biosimilars Leadership with Investment in a New World-Class Global Biotechnology Center in China Business Wire
11:01PM  Pfizer Bolsters China Presence With $350 Million Plant at Bloomberg
09:42PM  The Largest Drug Pipelines Will Surprise You
06:08PM  Carl Icahn Says Allergan Is Undervalued, Takes a Large Position
01:50PM  Could Chili Peppers Be The Answer To Opioid-Reliance For Chronic Pain?
01:32PM  Best Stocks to Buy in a Crash at Motley Fool
09:04AM  All aboard the Moat Investing Train!
08:11AM  Short Sellers Increase Bets Against Major Pharmaceutical Stocks at 24/7 Wall St.
08:10AM  Teva's Cinqaero Gets Positive CHMP View, Decision in 2H16
12:01AM  Chili Peppers Could Free Us From Opioids
Jun-25-16 08:43AM  Brexit Will Be Bad For Pharma at Forbes
Jun-24-16 04:39PM  Brexit may make health care stocks a good defensive play at MarketWatch
01:21PM  Pfizer Completes Anacor Acquisition
11:08AM  Amgen Fits Into Pfizer's Restructuring Plans Perfectly
09:12AM  Allergan (AGN) Gets FDA Nod for Avycaz Label Expansion
09:00AM  Pfizer Completes Acquisition of Anacor Business Wire
Jun-23-16 08:37PM  Why Pfizer (PFE) is a Great Stock to Buy for the Long Run
05:56PM  Arkansas Supreme Court upholds lethal injection protocols Reuters
04:00PM  Pfizer Declares 30-Cent Third-Quarter 2016 Dividend Business Wire
08:51AM  Nymox (NYMX) Stock Up on Positive 7-Year Fexapotide Data
08:05AM  20 Companies Buying Back the Most Stock in 2016 at 24/7 Wall St.
06:55AM  Five companies that could buy Ariad this year for as much as $2.9B at
Jun-22-16 08:18PM  Jim Cramer's 'Mad Money' Recap: We Need More Mergers Right Now
02:58PM  U.S. companies spent record amount on buybacks over past 12 months at MarketWatch
09:40AM  This biotech start-up is betting your genes will yield the next wonder drug at CNBC
Jun-21-16 06:39PM  U.S. Market Indexes Gain as Investors Await UK Vote
04:01PM  The 4 Stocks That Lifted the Dow on Tuesday at 24/7 Wall St.
03:52PM  7 Profitable Medical Stocks Ranked as Buys Now
03:03PM  7 Pharmaceutical Stocks With Dividends Yielding More Than 3% at Motley Fool
10:00AM  Pfizer Invites Public To View And Listen To Webcast Of August 2 Conference Call With Analysts Business Wire
07:56AM  A Cheap Lunch From a Pharma Rep Can Influence Doctors Prescriptions at Fortune
07:14AM  Pfizer Stock Rises Despite Price Target Cut (PFE) at Investopedia
Jun-20-16 03:16PM  Rx pizza: 1 free meal can sway doctor prescribing
02:15PM  Street Talk: Corning, Yelp & more
11:21AM  Anthem & Cigna: Will Regulator Kill Another Big Merger? at
09:07AM  Pfizer (PFE) Stock Price Target Cut at Jefferies
08:55AM  Top Analyst Upgrades and Downgrades: Chesapeake Energy, Motorola Solutions, Pfizer, Spirit Air, Symantec, Under Armour, US Foods and More at 24/7 Wall St.
07:05AM  Early movers: AAPL, ANTM, FDML, YELP, PFE, SAVE & more at CNBC
04:46AM  Calls For Actions Grow Louder
Jun-19-16 07:23AM  3 Top Big Pharma Stocks to Buy Now at Motley Fool
Jun-18-16 11:00AM  Meet the Marijuana Industry Money-Man, Rob Hunt of Tuatara Capital
Jun-17-16 05:26PM  Stocks to give dad
04:01PM  The 4 Stocks That Tanked the Dow on Friday at 24/7 Wall St.
11:03AM  Paratek Reports Positive Phase III Data on Antibiotic Drug
10:49AM  Here's When You Should Buy Pfizer
07:00AM  Allergan Carves Middle Path In R&D Spending With 'Open Science'
Jun-16-16 07:46PM  Don't Make it Complicated, Own Drug Stocks
09:00AM  Help Pfizer Change The Future Of Healthy Aging Business Wire
08:30AM  Pfizer Breaks Ground On New Biologics Clinical Manufacturing Facility In Andover, Massachusetts Business Wire
Jun-15-16 07:00PM  Cramer Remix: The Fed meetings over but caution ahead
05:26PM  Will A New Suitor For Anacor Emerge? at Forbes
05:19PM  Shire Buys Global Rights to Pfizer's Gastrointestinal Drug
04:01PM  The 4 Stocks That Weighed on the DJIA Wednesday at 24/7 Wall St.
03:00PM  Is Investment Banking Peaking? (PFE, AGN) at Investopedia
09:45AM  Infinity (INFI) at 52-Week Low on Disappointing Duvelisib Data
09:30AM  Zacks Industry Rank Analysis Highlights: Pfizer, Bristol-Myers Squibb and H Lundbeck
09:12AM  ICON and Pfizer Extend Ties, Sign New Agreement
Jun-14-16 06:18PM  Shire Gets Breakthrough Status for Rare Disease Candidates
04:44PM  U.S. regulator says too many drugmakers chasing same cancer strategy Reuters
01:37PM  Don't Make It Complicated, Own Drug Stocks
12:01PM  If I Plan On Investing My Social Security, What Dividend Stocks Can I Buy? at Motley Fool
09:55AM  Pfizer and Shire Move on IBD License Agreement
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments. The GIP segment develops and commercializes medicines for various therapeutic areas, including inflammation/immunology, cardiovascular/metabolic, neuroscience/pain, and rare diseases. The VOC segment develops and commercializes vaccines, as well as products for oncology and consumer healthcare. It provides over-the-counter products comprising dietary supplements under the Centrum, Caltrate, and Emergen-C brands; pain management products under the Advil and ThermaCare brands; gastrointestinal products under the Nexium 24HR/Nexium Control and Preparation H brands; and respiratory and personal care products under the brand names of Robitussin, Advil Cold & Sinus, Advil Sinus Congestion Relief & Pain, Dimetapp, and ChapStick. The GEP segment offers products that have lost marketing exclusivity in various markets; and branded generics, generic sterile injectable products, biosimilars, infusion systems, and other products. The company serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. It has licensing agreements with Cellectis SA and AstraZeneca PLC; and collaborative agreements with Eli Lilly & Company, OPKO Health, Inc., BioRap Technologies LTD., and Merck KGaA. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DAMELIO FRANK AExecutive Vice PresidentMay 26Option Exercise24.43100,0002,443,000472,994May 27 11:03 AM
DAMELIO FRANK AExecutive Vice PresidentMay 26Sale34.49100,0003,449,115372,994May 27 11:03 AM
CANGIALOSI LORETTA VSr. Vice President, ControllerMay 24Option Exercise25.8786,0002,224,820271,663May 26 10:07 AM
CANGIALOSI LORETTA VSr. Vice President, ControllerMay 24Sale33.9786,0002,921,147185,663May 26 10:07 AM
YOUNG JOHN DGroup PresidentMay 10Option Exercise25.8741,7001,078,779200,399May 11 06:04 PM
DAMELIO FRANK AExecutive Vice PresidentMay 10Option Exercise24.43192,0004,690,560564,994May 11 06:04 PM
YOUNG JOHN DGroup PresidentMay 10Sale33.5341,7001,398,277158,699May 11 06:04 PM
DAMELIO FRANK AExecutive Vice PresidentMay 10Sale33.66192,0006,462,579372,994May 11 06:04 PM
READ IAN CChairman & CEOMay 09Option Exercise25.74275,0007,078,2501,471,738May 11 06:03 PM
SUSMAN SALLYExecutive Vice PresidentMay 09Option Exercise22.2823,884532,136199,735May 11 04:35 PM
HILL CHARLES HExecutive Vice PresidentMay 09Sale33.8429,6001,001,65160,828May 11 04:35 PM
SUSMAN SALLYExecutive Vice PresidentMay 09Sale33.7167,8842,288,669131,851May 11 04:35 PM
READ IAN CChairman & CEOMay 09Sale33.80275,0009,295,0391,196,738May 11 06:03 PM
SUSMAN SALLYExecutive Vice PresidentMay 05Option Exercise22.2856,0161,248,036231,867May 06 09:51 AM
SUSMAN SALLYExecutive Vice PresidentMay 05Sale33.7156,0161,888,144175,851May 06 09:51 AM
SUSMAN SALLYExecutive Vice PresidentMay 04Option Exercise22.2820,100447,828195,951May 06 09:51 AM
SUSMAN SALLYExecutive Vice PresidentMay 04Sale33.8720,100680,762175,851May 06 09:51 AM
DAMELIO FRANK AExecutive Vice PresidentMay 03Sale33.6587,0792,930,208372,994May 05 05:27 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 24Option Exercise18.90110,9812,097,541274,756Feb 26 03:05 PM
MADDALUNA ANTHONY JExecutive Vice PresidentFeb 24Option Exercise18.9062,4531,180,362140,772Feb 26 03:05 PM
OLSON LAURIE JExecutive Vice PresidentFeb 24Option Exercise18.9018,984358,79889,467Feb 26 03:05 PM
READ IAN CChairman & CEOFeb 24Option Exercise18.90584,11211,039,7172,030,151Feb 26 03:05 PM
SUSMAN SALLYExecutive Vice PresidentFeb 24Option Exercise18.90110,9812,097,541263,151Feb 26 03:05 PM
YOUNG JOHN DGroup PresidentFeb 24Option Exercise18.9052,570993,573188,679Feb 26 03:05 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 24Option Exercise18.9034,171645,832210,943Feb 26 03:05 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 24Option Exercise18.90210,2803,974,292622,467Feb 26 03:05 PM
Dolsten MikaelPresident R&DFeb 24Option Exercise18.90210,2803,974,292577,902Feb 26 03:05 PM
HILL CHARLES HExecutive Vice PresidentFeb 24Option Exercise18.9078,8551,490,360149,135Feb 26 03:05 PM
JOHNSON RADY AExecutive Vice PresidentFeb 24Option Exercise18.9019,188362,65366,048Feb 26 03:05 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 24Option Exercise18.9034,171645,832149,482Feb 26 03:05 PM
BOURLA ALBERTGroup PresidentFeb 24Option Exercise18.9030,666579,587144,675Feb 26 03:03 PM
BOURLA ALBERTGroup PresidentDec 15Option Exercise26.2030,000786,000140,560Dec 16 06:46 PM
YOUNG JOHN DGroup PresidentDec 14Option Exercise26.2031,500825,300163,999Dec 16 06:55 PM
PFIZER INC10% OwnerOct 06Buy7.00714,2854,999,9952,253,509Oct 07 05:42 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerJul 30Sale35.6524,704880,646174,611Aug 03 07:24 AM